This week is the official commencement of our new Centre of Excellence in Treatable Traits! To kick off we have launched our twitter acc. & logo. We are really excited to generate #treatabletraits knowledge, collaborate, translate and train the next generation. Follow us 4 more!
1/5 We are excited to launch the Centre of Excellence in #TreatableTraits! It is an international collaboration aiming to revolutionise chronic #airway disease management. Our team include:
Bronchoscopy & Pleural Workshop underway for @tsanz_thoracic 2024 Hub. Thx to facilitators: @vin_george2 @JeevanGERRARD10 Dan Steinfort +Tracy Leong +Lou Irving and the Northern Hosp pleural team @NCARD_research @uwanews @TOGAANZ
Bushfire smoke can harm your health, especially if you live with a lung disease! Our friends over at Centre for Safe Air have developed an a Bushfire Smoke fact sheet to help you get prepared: https://t.co/FzXnFZTZQ9
Prof Anne Holland provides an overview of the European Respiratory Society Clinical Practice Guideline on Symptom Management -including breathlessness and fatigue-for Adults with Serious Respiratory Illness
#WorldLungDay advocates for the right of all people to Clean Air & Healthy Lungs. We support @FIRS_LungsFirst message to encourage communities & governments to invest in #lunghealth & combat #airpollution.
For more head to our clinical resources page https://t.co/GPK8YSRDx6
A treatable traits approach to physiotherapy and nursing care in Bronchiectasis. Congrats Kirsty Watson on your 2nd PhD study @ZoeMcKeough, Tiffany Dwyer, @AnnemarieLLee1
OMG! 4 years of my life will be presented at #ERSCongress2024. For those not in the room, I will live tweet the results of the ABRA trial (Acute BenRAlizumab for exacerbations). @MonaBafadhel is setting off 🧵
Join us for the TSANZ Education Hub in Melbourne from the 10 to 12 October, 2024. The Education Hub consists of a carefully curated program that aims to educate and foster collaboration and dialogue that can lead to tangible improvements in lung health #tsanz#tsanzeducation
Hot off the press!
Article Alert: Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma: A Secondary Analysis of a Randomized, Double-Anonymized, Placebo-Controlled Trial.
#asthma#remission
https://t.co/pwM5zEHg2L
Join us for the TSANZ Education Hub in Melbourne from the 10 to 12 October, 2024. The Education Hub is a conference that consists of a carefully curated program that aims to educate and foster collaboration and dialogue that can lead to tangible improvements in lung health.
Join us for the 2024 @tsanz_thoracic Education Hub. It promises to be a great meeting with something for everyone! Early 🦜ends 26/7!
https://t.co/SPSg0JnvdG
Mundipharma's new agreement with #BigTobacco giant PMI's inhaler device manufacturer @VecturaGroup crosses the red line set by respiratory organisations in 2021.
@tsanz_thoracic has adopted a principled but practical approach to the new agreement.
Read: https://t.co/1feF2ThKmb